Desensitization Protocol for Deceased Donor List

Status Completed

Clinical Trial Summary

Purpose of the study:

The specific aims of this study are to evaluate overall efficacy and safety of the pre-transplant IVIG treatment in our transplant center since 2007 and to identify factors affecting treatment outcomes in order to improve patient selection and treatment protocols for future patients.

Clinical Trial Description

Background:

Intravenous immunoglobulin (IVIG) infusion is one of several novel approaches to decrease antibody levels for highly sensitized kidney transplant candidates [1, 2]. This approach can potentially give a chance of kidney transplantation to end-stage renal failure patients who could never receive transplantation because of high levels of antibodies and persistent positive crossmatches to all potential kidney donors. Many transplant centers have used this strategy in order to increase transplant rates of highly sensitized patients with various levels of anti-HLA antibodies. However, the responses to the treatment seem to be different in each patient and factors affecting treatment outcome have yet to be determined. ;

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01642225
Study type	Observational
Source	University of Miami
Contact
Status	Completed
Phase	N/A
Start date	June 2012
Completion date	June 2014

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT00856895` - Quality of Life in Pre and Post Renal Transplant in Hispanic and Non-Hispanic Recipients
Completed	`NCT01680861` - Tacrolimus/Everolimus Versus Tacrolimus/Enteric-Coated Mycophenolate Sodium	Phase 3
Recruiting	`NCT01883583` - Pilot Study of Contrast-Enhanced Ultrasound of Transplanted Kidney	N/A
Terminated	`NCT01679184` - XM-One Study for Living Donor Program	N/A
Completed	`NCT01709097` - Compliance/Adherence After Kidney Transplant, With or With Out Med-O-Wheel™.	N/A
Completed	`NCT02213068` - Belatacept 3 Month Post Transplant Conversion Study	Phase 4
Recruiting	`NCT01631058` - Renal Transplantation in the Elderly - nEverOld Study	Phase 4
Terminated	`NCT01163799` - A Pilot Study to Assess the Safety and Efficacy of Alefacept in de Novo Kidney Transplant Recipients	Phase 1
Completed	`NCT01913392` - Effect of Laparoscopic Sleeve Gastrectomy in the Morbidly Obese, Kidney Transplant Candidate
Completed	`NCT01044303` - Reducing Donor Specific Antibody (DSA) Strength in Maintenance Kidney Transplant Recipients (DSA Study)	Phase 4
Completed	`NCT00587158` - Oral Paricalcitol in Kidney Transplant Recipients	N/A
Terminated	`NCT01441570` - The Impact of Nebivolol Versus Metoprolol on Quality of Life	N/A
Completed	`NCT01172418` - Randomized Trial of 2 Antibody Induction Steroid Avoidance Protocols	Phase 4
Completed	`NCT02559297` - Effects of Sevoflurane and Desflurane on Treg	Phase 2